Global Medical Tourism Market Size study, by Type, Application and Regional Forecasts 2021-2026

The MarketWatch News Department was not involved in the creation of this content.

Feb 02, 2021 (Heraldkeepers) —
Medical Tourism Market:

WiseGuyReports.com adds “Global Medical Tourism Market Research Report 2021 Analysis and Forecast 2026” reports to its database.

Executive Summary

Major players in the medical tourism market are Apollo Hospital Enterprise Limited, Prince Court Medical Center, Bumrungrad International Hospital, KPJ Healthcare Berhad, and Fortis Health Ltd.

The global medical tourism market is expected to decline from $37.72 billion in 2019 to $19.8 billion in 2020 at a compound annual growth rate (CAGR) of -47.53%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, restriction on cross-border travel and the closure of industries and other commercial activities. The ban on cross-border travel reduces the number of international patients, impacting the market. The market is then expected to recover and

Read More

Regional medical staff, 1B patients share their symptoms and emotions after receiving COVID vaccine | Local News

Representatives of Our House Senior Living Assisted Care & Memory Care, Chippewa Falls.

Residents have been waiting a long time for their chance to receive the COVID-19 vaccine and (resident) Pete (Dachel) was the first in line, wide awake and ready to go. He took the lead and we all followed.

A statement from Maggie Smith, MCHES, CPSTI, La Crosse County Health Department health educator and COVID-19 public information officer

Although our department is the lead agency in coordinating vaccine distribution, the majority of our staff were not included in Phase 1A or 1B guidelines from the state.

We continue to adhere to the equitable, ethical allocation coordinated by the Wisconsin Department of Health Services, though we like so many others are eagerly awaiting our turn to receive the vaccine. We ask the community for patience as vaccine rollout continues. The speed of the process is dependent on availability

Read More

Paris Regional Medical Center offering monoclonal antibody treatment for Covid-19 patients | Free

Paris Regional Medical Center announced today that it is offering both bamlanivimab/casirivimab and imdevimab, new monoclonal antibody therapies, for treatment of non-hospitalized patients with a mild or moderate case of Covid-19.

Developed by pharmaceutical companies Eli Lilly/Regeneron Pharmaceuticals Inc., the drug recently received emergency use authorization from the Food and Drug Administration and is now being allocated by the U.S. Department of Health and Human Services in partnership with the Texas Department of State Health Services and other state agencies.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses. Bamlanivimab/casirivimab and imdevimab are specifically designed to help block the SARS-CoV-2 virus and prevent the virus from further infecting healthy cells. Administered intravenously, this innovative treatment is designed to help lessen the severity of Covid-19 in individuals who test positive and are at risk for developing a severe form of the disease.

“Paris Regional

Read More